Sara Bonstein
Director of Finance/CFO at INSMED INCORPORATED
Net worth: 3 M $ as of 29/04/2024
Sara Bonstein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INSMED INCORPORATED | Director of Finance/CFO | 30/01/2020 | - |
| SCPHARMACEUTICALS INC. | Director/Board Member | 07/07/2020 | - |
| Independent Dir/Board Member | 07/07/2020 | - | |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 16/08/2021 | - |
| Independent Dir/Board Member | 16/08/2021 | - |
Career history of Sara Bonstein
Former positions of Sara Bonstein
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Operating Officer | 30/04/2018 | 29/01/2020 |
| Director of Finance/CFO | 30/04/2018 | 29/01/2020 | |
| Corporate Secretary | 30/04/2018 | 29/01/2020 | |
| AYALA PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/01/2014 | 29/04/2018 |
| Corporate Secretary | 31/01/2014 | 29/04/2018 | |
| Treasurer | 31/01/2014 | 29/04/2018 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 31/07/2004 | 31/01/2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Training of Sara Bonstein
| The College of New Jersey | Undergraduate Degree |
| Rider University | Masters Business Admin |
Statistics
International
| United States | 10 |
Operational
| Director of Finance/CFO | 3 |
| Corporate Secretary | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| INSMED INCORPORATED | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| SCPHARMACEUTICALS INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Sara Bonstein
- Experience
